These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 37447622)

  • 1. Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
    Cersosimo E; Alatrach M; Solis-Herrera C; Baskoy G; Adams J; Hansis-Diarte A; Gastaldelli A; Chavez A; Triplitt C; DeFronzo RA
    J Clin Endocrinol Metab; 2023 Dec; 109(1):161-170. PubMed ID: 37481263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparison of three different molecular imaging methods in localization and grading of insulinoma.
    Chang L; Bi X; Li S; Tong Q; Gu Y; He Z; Li Y; Chen Q; Cui J; Yu H; He Q; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1163176. PubMed ID: 37455905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Almutairi et al. Application of Chitosan/Alginate Nanocomposite Incorporated with Phycosynthesized Iron Nanoparticles for Efficient Remediation of Chromium.
    Almutairi FM; El Rabey HA; Alalawy AI; Salama AAM; Tayel AA; Mohammed GM; Aljohani MM; Keshk AA; Abbas NH; Zayed MM
    Polymers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Exenatide loaded Biotinylated Trimethylated Chitosan/HP- 55 Nanoparticles.
    Guo H; Yan X; Tang H; Zhang X
    Curr Drug Deliv; 2022; 19(1):32-40. PubMed ID: 34126896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Siddhardha et al. Chrysin-Loaded Chitosan Nanoparticles Potentiates Antibiofilm Activity against
    Siddhardha B; Pandey U; Kaviyarasu K; Pala R; Syed A; Bahkali AH; Elgorban AM
    Pathogens; 2023 Dec; 13(1):. PubMed ID: 38251393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats.
    Yang JM; Wu LJ; Lin MT; Lu YY; Wang TT; Han M; Zhang B; Xu DH
    Polymers (Basel); 2022 May; 14(11):. PubMed ID: 35683851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan Nanoparticles as Oral Drug Carriers.
    Guadarrama-Escobar OR; Serrano-Castañeda P; Anguiano-Almazán E; Vázquez-Durán A; Peña-Juárez MC; Vera-Graziano R; Morales-Florido MI; Rodriguez-Perez B; Rodriguez-Cruz IM; Miranda-Calderón JE; Escobar-Chávez JJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Yang et al. Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats.
    Yang JM; Wu LJ; Lin MT; Lu YY; Wang TT; Han M; Zhang B; Xu DH
    Polymers (Basel); 2023 Jun; 15(13):. PubMed ID: 37447622
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.